The FDA has authorized Novavax's new formula, adding to a repertoire of revamped COVID vaccines. Here's what to know about cost and more. Jessica Rendall Wellness Reporter Jessica is a writer on ...

Doses of Novavax's 2024-2025 Formula COVID-19 vaccine now available at thousands of locations nationwide Novavax's updated vaccine is the only protein-based option available in the U.S. this fall ...

Novavax's exclusive dependence on Serum Institute of India Pvt. Ltd. for co-formulation and filling and the impact of any delays or disruptions in their operations on the delivery of customer ...

The U.S. Food and Drug Administration on Friday granted emergency use authorization for an updated version of Novavax's COVID shot. The updated vaccine is authorized for use in individuals 12 ...

Novavax received the green light from the Food ... In May, it struck a $1.2 billion licensing agreement with French drugmaker Sanofi to co-commercialize the combination vaccine.

COVID-19 Positive Rate Spikes With more knowledge about the virus, ample funding, and new treatments, the worst of the ...

The Food and Drug Administration approved an updated coronavirus vaccine manufactured by Novavax Friday, days after new mRNA coronavirus vaccines manufactured by Pfizer-BioNTech and Moderna ...

AND IF YOU DON’T WANT TO GET AN MRNA VACCINE, YOU CAN ALSO GET NOVAVAX, WHICH IS A PROTEIN VACCINE. OKAY, ANY ADVICE FOR THOSE WHO ARE THINKING, YES, LET’S GET IT. AND WE DON’T HAVE ANY RISK ...

The Food and Drug Administration approved Novavax’s new COVID-19 vaccine Friday, a week after giving Pfizer and Moderna the OK on their shots, though all drugmakers say their shots will be ...

Vaccine maker Novavax (NASDAQ: NVAX) is having a good year. In May, the company announced a lucrative partnership with French biotech giant Sanofi (NASDAQ: SNY), sending its stock price soaring.